Cigna Group (CI)
(Delayed Data from NYSE)
$293.76 USD
-2.83 (-0.95%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $293.86 +0.10 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CI 293.76 -2.83(-0.95%)
Will CI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CI
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
Will UnitedHealth's Push for Access to Trump Calm Investor Jitters?
CI: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Health Trades Cheaper Than Industry: How to Play the Stock?
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?
Food as Medicine: Elevance Health & NACHC Integrate Nutrition in Care
Other News for CI
Bollinger Band Squeeze appears for CI after 0.81% move
Obamacare tax credits could expand budget deficit by $350B if extended, CBO says
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
CI forms 50 Day Moving Average Support on September 16
Cantor Fitzgerald Remains a Buy on Cigna (CI)